Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) announced a quarterly dividend on Wednesday, January 7th. Investors of record on Saturday, February 28th will be given a dividend of 0.16 per share by the medical instruments supplier on Monday, March 16th. This represents a c) annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, February 27th.
Mesa Laboratories has a dividend payout ratio of 5.2% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Mesa Laboratories to earn $8.72 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.3%.
Mesa Laboratories Stock Performance
NASDAQ MLAB opened at $95.24 on Wednesday. The firm has a market cap of $525.72 million, a P/E ratio of 148.81 and a beta of 0.89. The company has a quick ratio of 1.45, a current ratio of 1.94 and a debt-to-equity ratio of 0.86. The business’s 50-day moving average price is $85.44 and its 200 day moving average price is $76.63. Mesa Laboratories has a 52-week low of $55.45 and a 52-week high of $147.59.
About Mesa Laboratories
Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.
The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.
Read More
- Five stocks we like better than Mesa Laboratories
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
